STOCKHOLM, Oct. 20, 2023 /PRNewswire/ -- Medivir AB (Nasdaq:MVIR) and (Stockholm:MVIR.SS), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that the company's board member Anette Lindqvist has informed the board of directors that she is leaving her position due to personal reasons.
Read more at prnewswire.comChange in Medivir's Board of Directors
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/A%20concept%20image%20of%20space_%20Image%20by%20Canities%20via%20Shutterstock_.jpg)
/A%20concept%20image%20of%20a%20flying%20car_%20Image%20by%20Phonlamai%20Photo%20via%20Shutterstock_.jpg)
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)